You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ICC

Showing 1 - 25 of 1,161
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Intrahepatic Cholangiocarcinoma Trial in Shanghai (Cryoablation, Sintilimab, Lenvatinib)

Recruiting
  • Advanced Intrahepatic Cholangiocarcinoma
  • Cryoablation
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 28, 2023

Combined Hepatocellular Cholangiocarcinoma Trial (gemcitabine ,oxaliplatin,anlotinib,Sintilimab)

Not yet recruiting
  • Combined Hepatocellular Cholangiocarcinoma
  • gemcitabine ,oxaliplatin,anlotinib,Sintilimab
  • (no location specified)
Sep 10, 2023

HIV Trial in Chennai (Incentives, Integrated Care Centers)

Active, not recruiting
Has Results
  • HIV Infections
  • Incentives
  • Integrated Care Centers
  • Chennai, Tamil Nadu, India
    YR Gaitonde Center for AIDS Research and Education
Feb 1, 2023

Cholangiocarcinoma Trial in Birmingham (Novel combination of chemo and immunotherapy)

Recruiting
  • Cholangiocarcinoma
  • Novel combination of chemotherapy and immunotherapy
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jul 28, 2022

Cholangiocarcinoma Trial in Nanjing (HAIC combined with donafenib and sintilimab)

Not yet recruiting
  • Cholangiocarcinoma
  • HAIC combined with donafenib and sintilimab
  • Nanjing, Jiangsu, China
    Zhongda Hospital, Southeast University
Apr 20, 2022

Violence Trial in Islamabad (Interaction Competencies with Children - for Teachers (ICC-T))

Not yet recruiting
  • Violence
  • Interaction Competencies with Children - for Teachers (ICC-T)
  • Islamabad, Pakistan
    Shifa International Hospitals
Aug 21, 2023

Intrahepatic Cholangiocarcinoma Trial in Shanghai (Cadonilimab+Gem/Cis)

Active, not recruiting
  • Intrahepatic Cholangiocarcinoma
  • Shanghai, Shanghai, China
    Eastern hepatobilliary surgery hospital
Mar 22, 2023

Postoperative Analgesia Trial in Basel (Ropivacain, NaCl 0.9%)

Recruiting
  • Postoperative Analgesia
  • Basel, Switzerland
    University Hospital Basel, Department of Thoracic Surgery
Jan 24, 2022

Intrahepatic Cholangiocarcinoma Trial in Shanghai (Toripalimab, Lenvatinib mesylate capsules, Placebo IV)

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Shanghai, Shanghai, China
    Zhongshan Hospital affiliated to Fudan University
Aug 12, 2022

Cerebral Blood Flow, Cognitive Function Trial in HangZhou (Nattokinase, Placebo)

Recruiting
  • Cerebral Blood Flow
  • Cognitive Function
  • HangZhou, Zhejiang, China
    Second Affilated Hospital of Zhejiang University, School of Medi
Apr 1, 2022

Peripheral ICC Trial in Royal Oak (Hydrophilic Biomaterial, Thermoplastic Polyurethane)

Terminated
Has Results
  • Peripheral ICC
  • Hydrophilic Biomaterial
  • Thermoplastic Polyurethane
  • Royal Oak, Michigan
    Beaumont Hospital
Nov 3, 2022

Violence by Teachers Trial in Cap-Haitien (Interaction Competencies with Children - for Teachers (ICC-T))

Recruiting
  • Violence by Teachers
  • Interaction Competencies with Children - for Teachers (ICC-T)
  • Cap-Haitien, Haiti
    P4H Global
Dec 14, 2021

Vascular Positioning System G4 Algorithm ECG Data Collection for

Not yet recruiting
  • Peripheral ICC
  • Digital ECG Data Collection
  • Durham, North Carolina
    Duke University Hospital
Jan 25, 2023

Cholangiocarcinoma Trial in Beijing (autologous Tcm cellular immunotherapy)

Recruiting
  • Cholangiocarcinoma
  • autologous Tcm cellular immunotherapy
  • Beijing, China
    Peking Union Medical College Hospital
Apr 24, 2022

Intrahepatic Cholangiocarcinoma Trial in Hangzhou (Tislelizumab combined with GEMOX (GOT) regimen)

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Tislelizumab combined with GEMOX (GOT) regimen
  • Hangzhou, Zhejiang, China
    1# Banshan East Rd. Zhejiang cancer hospital
Sep 24, 2022

Cholangiocarcinoma, Intrahepatic Trial in Shanghai (Capecitabine, PD-1 Antibody(Tislelizumab))

Recruiting
  • Cholangiocarcinoma, Intrahepatic
  • Shanghai, China
    Lulu@Huashan.Org.Cn
Aug 16, 2022

Potentially Resectable Locally Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer Trial in Tianjin

Recruiting
  • Potentially Resectable Locally Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Nov 16, 2022

Intrahepatic Cholangiocarcinoma Trial (DEB-TACE combined with Surufatinib and Camrelizumab)

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • DEB-TACE combined with Surufatinib and Camrelizumab
  • (no location specified)
Feb 9, 2022

Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

Not yet recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 25, 2023

Violence by Teachers Trial in Abetifi, Daressalam, Mbarara (Interaction Competencies with Children - for Teachers (ICC-T))

Recruiting
  • Violence by Teachers
  • Interaction Competencies with Children - for Teachers (ICC-T)
  • Abetifi, Ghana
  • +2 more
Oct 4, 2021

Intrahepatic Cholangiocarcinoma Trial in Guangzhou (Camrelizumab, Apatinib)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Guangzhou, Guangdong, China
    Li Xu
Dec 8, 2021

ICC, Metastatic Cancer Trial in Guangzhou (Folfirinox, Sintilimab)

Withdrawn
  • ICC
  • Metastatic Cancer
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
Feb 1, 2021

ICC Trial in Guangzhou (Systemic Chemotherapy, Sintilimab, Apatinib)

Withdrawn
  • ICC
  • Systemic Chemotherapy
  • +2 more
  • Guangzhou, Guangdong, China
    Cancer Center Sun Yat-sen University
Feb 1, 2021

Metastatic Colorectal Cancer (Mcrc), Intrahepatic Cholangiocarcinoma (Icc), Colorectal Cancer Trial run by the National Cancer

Recruiting
  • Metastatic Colorectal Cancer (Mcrc)
  • +7 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Incidental Gallbladder Carcinoma, Biliary Tract Cancer Trial in Frankfurt (Gemcitabine, Cisplatin, Oncologically radical

Recruiting
  • Incidental Gallbladder Carcinoma
  • Biliary Tract Cancer
  • Frankfurt, Germany
    Krankenhaus Nordwest gGmbH
Sep 7, 2022